Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825)

Minesh Mehta

Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825)

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-oncology
Volume	23
State	Published - Jul 1 2021

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{2aa435b1ce35444aa7c4768111af3e83,

title = "Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825)",

author = "Minesh Mehta",

note = "Neuro-Oncology (2021) 23(7):1125-1138.",

year = "2021",

month = jul,

day = "1",

language = "American English",

volume = "23",

journal = "Neuro-oncology",

}

TY - JOUR

T1 - Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825)

AU - Mehta, Minesh

N1 - Neuro-Oncology (2021) 23(7):1125-1138.

PY - 2021/7/1

Y1 - 2021/7/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3798

M3 - Article

VL - 23

JO - Neuro-oncology

JF - Neuro-oncology

ER -

Neurocognitive, Symptom, and Health- Related Quality of Life Outcomes of a Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (NRG/RTOG 0825)

Access to Document

Other files and links

Cite this